About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Therapeutic Target to Prevent Alzheimer's Progression Identified

by VR Sreeraman on September 22, 2010 at 5:25 PM
Font : A-A+

 New Therapeutic Target to Prevent Alzheimer's Progression Identified

Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease.

The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

Advertisement

"There are multiple, neurotoxic, disease-causing pathways that converge on the neutral sphingomyelinase that can cause neuronal loss in the brain of an Alzheimer's patient," said Kalipada Pahan, PhD, neurological researcher and lead investigator at Rush.

"If we can stop the activation of the neutral sphingomylinase, we may be able to stop memory loss and the progression of Alzheimer's disease," he said.
Advertisement

In the brain of a patient with Alzheimer's disease, two abnormal structures called plaques and tangles are prime suspects in damaging and killing nerve cells.

While neurons die, other brain cells like astroglia and microglia do not die. These cells become activated and glial cell activation plays a key role in the destruction of neurons.

However, the molecular mechanisms by which activated glial cells can kill neurons have been poorly understood until now.

Beta-amyloid, which is a protein fragment deposited in the brains of patients who have Alzheimer's disease, causes the activation of glial cells.

Neuritic plaques are mainly composed of aggregates of beta-amyloid.

When healthy nerve cells in the brain are exposed to beta-amyloid, they exhibit a number of pathological changes that are characteristic of Alzheimer's pathology.

Researchers at Rush were able to determine that the neutral sphingomyelinase is triggered by the activated brain cells and beta-amyloid.

However, when the neutral sphingomyelinase was inhibited by using a small molecule inhibitor and a chemical inhibitor, the activated brain cells and beta amyloid were unable to kill neurons.

Experts tested the two inhibitors using human brain cells in a mouse model and a cell culture model.

"Understanding how the disease process works is important in identifying effective approaches to protect the brain and stop the progression of Alzheimer's disease.

"The results of this study are very promising and our next step is to translate these findings to the clinic.

"If we can develop and test a clinical medication that can target the neutral sphingomyelinase, we may be able to halt memory loss in Alzheimer's disease patients," said Pahan.

Results from the study were published in the September 22 issue of the Journal of Neuroscience.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Creutzfeldt-Jakob Disease Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease 

Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
Caring for Alzheimers disease patients
Alzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The ...
World Alzheimer's Day - "Dementia: It's Time for Action"
September 21st 2010 is celebrated globally as World Alzheimer's Day with the theme "Dementia: .....
Alzheimer’s Disease Day: Treating Dementia with Care Rather Than Cure
Alzheimer's disease has no cure and patients need care more than cure, says Ravi Samuel, Cognitive ....
Creutzfeldt-Jakob Disease
Creutzfeldt-Jakob disease (CJD) is a rare form of degenerative brain disorder, or brain damage that ...
Diet and Alzheimer´s Disease
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with dra...
Genetics of Alzheimer´s disease
There are numerous genes that have been discovered that are associated with Alzheimer’s disease and ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use